Patents by Inventor Mohammad Baqer

Mohammad Baqer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LENALIDOMIDE PROCESS
    Publication number: 20240327374
    Abstract: The present invention provides to an improved process for the preparation of new and high purity crystalline Form SRA of 3-(4-amino-1-oxoisoindolin-2-yl) piperidine-2, 6-dione of formula (I) The pure crystalline Form SRA of compound of formula (I) obtained by the process of present invention is having purity of greater than 99.9% (area % by HPLC). Lenalidomide (I) pure crystalline Form SRA is useful in the treatment of cancer, inflammatory diseases, autoimmune diseases and Multiple myeloma.
    Type: Application
    Filed: March 31, 2023
    Publication date: October 3, 2024
    Inventors: Akshay Kant Chaturvedi, Mohammad Baqer, Bijan Kumar Panda, Satyaveer, Deepali Chaturvedi, Saroj Bala, Yogesh Tripathi
  • Polymorphic Forms of an HMG-CoA Reductase Inhibitor and Uses Thereof
    Publication number: 20080153896
    Abstract: The invention provides polymorphic forms of the HMG-CoA reductase inhibitor (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxymethylphenylamino)carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid, hemi calcium salt. The invention also provides methods for preparing these polymorphic forms, pharmaceutical formulations containing these polymorphic forms and methods of using the polymorphic forms of this HMG-CoA reductase inhibitor.
    Type: Application
    Filed: July 13, 2007
    Publication date: June 26, 2008
    Inventors: Gyan Chand Yadav, Mohammad Baqer, Vishwesh P. Pandya